Ammar, El-Sayed M <br/><br/>
Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.  [electronic resource] 

 -  Canadian journal of physiology and pharmacology  Apr 2011 
 - 269-76 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1205-7541 
<br/><br/><label>Standard No.: </label>10.1139/y11-020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aconitine--pharmacology<br/>Animals<br/>Antibiotics, Antineoplastic--adverse effects<br/>Creatine Kinase, MB Form--metabolism<br/>Deferiprone<br/>Doxorubicin--adverse effects<br/>Drug Interactions<br/>Electrocardiography--drug effects<br/>Glutathione--metabolism<br/>Heart--drug effects<br/>Heart Diseases--chemically induced<br/>Heart Rate--drug effects<br/>Iron--metabolism<br/>Iron Chelating Agents--pharmacology<br/>L-Lactate Dehydrogenase--metabolism<br/>Male<br/>Malondialdehyde--metabolism<br/>Myocardium--metabolism<br/>Pyridones--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reactive Oxygen Species--metabolism<br/>Superoxide Dismutase--metabolism<br/>Tachycardia, Ventricular--chemically induced